Innovation Observatory > Reports > Drugs > Ponesimod for Relapsing-remitting Multiple Sclerosis

< Back

Ponesimod for Relapsing-remitting Multiple Sclerosis


Neurology and Neurosurgery

December 2017

Ponesimod is a drug which works by blocking the signals which allow the body’s immune cells to travel to and damage the nerve cells. By preventing the immune cells from damaging the nerves, it is thought this drug will stop the damage which causes MS ‘relapses’. In clinical trials it has been shown that ponesimod reduces the number of ‘relapses’ in people with MS and reduced the amount of damage to the nerves (measured by brain scans) compared to a placebo.

Innovation Observatory Voice 0

Leave a Reply

Your email address will not be published. Required fields are marked *

Post Comment

Connect to the Innovation Observatory



Related Information

Ponesimod for Multiple Sclerosis

Load More Related Posts
Get Alerts